Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Efficacy and safety of Exubera (inhaled insulin) compared with subcutaneous human insulin therapy in adult subjects with type 2 diabetes mellitus: a long-term, outpatient, open-label, parallel-group comparative trial.

Trial Profile

Efficacy and safety of Exubera (inhaled insulin) compared with subcutaneous human insulin therapy in adult subjects with type 2 diabetes mellitus: a long-term, outpatient, open-label, parallel-group comparative trial.

Discontinued
Phase of Trial: Phase III

Latest Information Update: 26 Jan 2010

At a glance

  • Drugs Insulin; Insulin
  • Indications Type 2 diabetes mellitus
  • Focus Adverse reactions
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 21 Jul 2008 Status changed from recruiting to discontinued, as reported by ClinicalTrials.gov.
    • 03 Jan 2008 The expected completion date for this trial is now 1 Mar 2010.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top